
Sign up to save your podcasts
Or


Jonathan Rosenberg returns to finish this two-part series on IO drug development in urothelial cancer
By The Uromigos4.9
5555 ratings
Jonathan Rosenberg returns to finish this two-part series on IO drug development in urothelial cancer

139 Listeners

318 Listeners

699 Listeners

499 Listeners

14 Listeners

58 Listeners

2,445 Listeners

3,348 Listeners

9,188 Listeners

196 Listeners

512 Listeners

2 Listeners

34 Listeners

189 Listeners

2 Listeners